Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Unspecified Adult Solid Tumor, Protocol Specific × intoplicine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 1

Interventions

PR-104 3 apomine 2 N-(4-(3-(1H-1,2,4-triazol-1-yl)-4-(3,4,5-trimethoxybenzoyl)phenyl)thiazol-2-yl)-2-amino-3-methylbutanamide 2 tesetaxel 1 ixabepilone 1 intoplicine 1 fluoromisonidazole 1 eribulin 1 Granulocyte Colony-Stimulating Factor 1 Gemcitabine 1 Filgrastim 1 Docetaxel 1 Capecitabine 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00003713 2018-08-29

Chemotherapy in Treating Patients With Advanced or Metastatic Solid Tumors

Sanofi

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon ⚡